Log In
Print this Print this

TBI 301

  Manage Alerts
Collapse Summary General Information
Company Therapure Biopharma Inc.
DescriptionConjugate of hemoglobin and ribavarin
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat acute and chronic Hepatitis C virus (HCV)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today